31 results on '"Bartlett, Emmalene J."'
Search Results
2. Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children
3. Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection
4. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein
5. Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates
6. Interferon Subtype Gene Therapy for Regulating Cytomegalovirus Disease
7. Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys
8. Type I IFN-β gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis
9. Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection
10. Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
11. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation
12. Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
13. Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium
14. Progress in the development of human parainfluenza virus vaccines
15. Epstein-Barr virus genetics: talking about the BAC generation
16. A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates
17. Efficacy and immunological mechanisms of type 1 interferon gene therapy in murine cytomegalovirus
18. The C Proteins of Human Parainfluenza Virus Type 1 (HPIV1) Control the Transcription of a Broad Array of Cellular Genes That Would Otherwise Respond to HPIV1 Infection
19. Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman Primates
20. Role of Interferon in the Replication of Human Parainfluenza Virus Type 1 Wild Type and Mutant Viruses in Human Ciliated Airway Epithelium
21. Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
22. Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1
23. Type I IFN‐β gene therapy suppresses cardiac CD8 + T‐cell infiltration during autoimmune myocarditis
24. Interferon Subtype Gene Therapy for Regulating Cytomegalovirus Disease.
25. Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+T cells
26. Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection.
27. Research Article Type I IFN-β gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis.
28. Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium
29. Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium
30. Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells.
31. Interferon subtype gene therapy for regulating cytomegalovirus disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.